As endothelial cells (EC) express heparin-like glycosaminoglycans, such as heparan sulfate, it was essential to investigate the relation of anti-EC antibody (AECA) to heparin reactivity. AECA were detected in 43 of 131 autoimmune sera and anti-heparin antibodies (AHA) in 25. These autoimmune reactivities were significantly associated (P corrected < 0.0005). Seven AECA-positive/AHA-positive and three AECA-negative/AHA-positive sera were affinity-purified using protein G column followed by a heparin-Sepharose column. Two populations of AECA were recovered from the second column. One was eluted with 0.4 M NaCl which bound to EC and to solid-phase heparin with low affinity, but not to soluble heparin. The second population of AECA, which was eluted with 4 M guanidine HCl=2 M NaCl, recognized EC and solid-phase heparin with high affinity, but also soluble heparin. The latter population of AECA might thus be an important cause of autoimmune vascular thrombosis in systemic diseases.
Meroni PL , Youinou P . Endothelial cell antibodies. In: Autoantibodies. Peter JB , Shoenfeld Y (eds). Elsevier: Amsterdam , 1996; pp 245–252.
2.
Youinou P , Meroni PL , Khamashta MA , Shoenfeld Y . A need for standardization of the antiendothelial cell antibody test . Immunol Today1995; 16: 363–364 .
3.
Salojin KV et al. Antiendothelial cell antibodies: useful markers of systemic sclerosis . Am J Med1997; 102: 178–185 .
4.
Del Papa N et al. Characterization of the anti-endothelial antibodies in primary and secondary autoimmune vasculitis . Clin Immunol Immunopathol1997; 70: 211–216 .
5.
Meroni PL . What is going to happen tomorrow in the field of antiendothelial cell autoantibodies related to vasculitis?Ann Méd Int (Paris)1994; 145: 467–468 .
6.
Kjellen L , Lindahl U . Proteoglycans: structure and interactions . Annu Rev Biochem1991; 60: 443–475 .
7.
Fillit H , Lahita R . Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus erythematosus . Autoimmunity1991; 9: 159–164 .
8.
Fillit H , Edstrom W , Yang CP , Moran T , Dimitriu-Bona A . Autoimmune MRL mice express high-affinity IgG2b monoclonal autoantibodies to heparin . Clin Immunol Immunopathol1996; 81: 62–67 .
9.
Chan TM , Yu PM , Tsang KLC , Cheng IKP . Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations . Clin Exp Immunol1995; 100: 506–513 .
10.
Direskeneli H , D'Cruz D , Khamashta MA , Hughes GRV . Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis . Clin Immunol Immunopathol1994; 70: 206–210 .
11.
Shibata S , Harpel PC , Gharavi A , Rand J , Fillit H . Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes . Blood1994; 83: 2532–2540 .
12.
Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum1982; 25: 1271–1277 .
13.
Hughes GRV . The antiphospholipid syndrome: ten years on . Lancet1993; ii: 341–344 .
14.
Vitali CDiagnostic criteria for Sjögren's syndrome: results of a European multicenter prospective study . Arthritis Rheum1993; 36: 340–347 .
15.
Masi AT et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma) . Arthritis Rheum1980; 23: 581–590 .
16.
Hunder GG et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis . Arthritis Rheum1990; 33: 1122–1128 .
17.
Lightfoot RW Jr , et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa . Arthritis Rheum1990; 33: 1088–1093 .
18.
Leavitt RY et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis . Arthritis Rheum1990; 33: 1101–1107 .
19.
Edgell CJS , McDonald CC , Graham JB . Permanent cell line expressing human factor VIII-related antigen established by hybridization . Proc Natl Acad Sci USA1983; 80: 3734–3737 .
20.
Bell WR , Royall RM . Heparin-associated thrombocytopenia: a comparison of three heparin preparations . N Engl J Med1980; 303: 902–907 .
21.
Le Tonquèze M et al. The relationship of anti-endothelial cell antibodies to anti-phospholipid antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica . Autoimmunity1995; 20: 59–66 .
22.
Dueymes M et al. Role of b2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune disease . Lupus1995; 4: 477–481 .
23.
Dueymes M et al. Relationship of interleukin-4 to isotypic distribution of anti-double stranded DNA antibodies in systemic lupus erythematosus . Int Arch Allergy Immunol1993; 101: 408–415 .
24.
Poulsen JH . Urine and tissue glycosaminoglycans and their interrelations . Dan Med Bull1986; 33: 75–96 .
25.
Hylkema MN et al. A new ELISA for the detection of anti-heparan sulfate reactivity using photobiotinglated antigen . J Immunol Methods1994; 176: 33–43 .
26.
Rumore PM , Steinman CR . Endogeneous circulating DNA in systemic lupus erythematosus . J Clin Invest1990; 86: 69–74 .
27.
Bush C , Ljungman D , Heldin CM , Wasteson A , O'Brink B . Surface properties of endothelial cells . Haemostasis1979; 8: 142–147 .
28.
Underhill CB . Naturally occurring antibodies which bind hyaluronate . Biochem Biophys Res Commun1982; 108: 1488–1494 .
29.
Ronda N et al. Analysis of natural and disease–associated autoantibody repertoire: antiendothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus . Int Immunol1994; 6: 1651–1660 .
30.
Arnout J . The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin induced thrombocytopenia . Thromb Haemost1996; 75: 536–541 .
31.
Le Tonquèze M et al. Establishment and characterization of permanent human endothelial cell clones . Lupus1996; 5: 103–112 .
32.
Cines DB , Tomaski A , Tannenbaum S . Immune endothelial cell injury in heparin-associated thrombocytopenia . N Engl J Med1987; 316: 581–589 .
33.
Amiral J et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia . Thromb Haemost1992; 68: 95–96 .
34.
Visentin GP , Ford SE , Scott P , Aster RH . Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet 4 complexed with heparin or bound to endothelial cells . J Clin Invest1994; 93: 81–88 .
35.
O'Brien JR , Etherington MD , Pashley M . Intra-platelet factor 4 (PF4) and the heparin mobilizable pool of PF4 in health and atherosclerosis . Thromb Haemost1984; 51: 354–357 .
36.
Busch C , Dawes J , Pepper DS , Wasteson A . Binding of platelet factor 4 to cultured human umbilical vein endothelial cells . Thromb Res1980; 19: 129–137 .
37.
Zucker MB , Katz IR . Platelet factor 4: production, structure and physiologic and immunologic action . Proc Soc Exp Biol Med1991; 198: 693–702 .
38.
Shibata S , Harpel P , Bona C , Fillit H . Monoclonal antibodies to heparan sulfate inhibit the formation of thrombin-antithrombin III complexes . Clin Immunol Immunopathol1993; 67: 264–272 .
